scholarly journals The real-life efficacy and safety of secukinumab therapy (150 and 300 mg) in patients with moderate-to-severe plaque psoriasis: A twelve week, single center, retrospective study

TURKDERM ◽  
2021 ◽  
Vol 55 (3) ◽  
pp. 113-118
Author(s):  
İncilay Kalay Yıldızhan ◽  
Merve Aygün ◽  
Nihal Kundakçı
Keyword(s):  
Retrospective Study ◽  
Plaque Psoriasis ◽  
Real Life ◽  
Efficacy And Safety ◽  
Single Center ◽  
Severe Plaque Psoriasis ◽  
The Real

scholarly journals Erratum: Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting

2021 ◽  
Vol 10 ◽  
pp. 1-1
Author(s):  
Martina Burlando ◽  
Riccardo Castelli ◽  
Emanuele Cozzani ◽  
Aurora Parodi
Keyword(s):  
Plaque Psoriasis ◽  
Real Life ◽  
Severe Plaque Psoriasis ◽  
The Real ◽  
Real Life Setting

scholarly journals Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting

2021 ◽  
Vol 10 ◽  
pp. 1-4
Author(s):  
Martina Burlando ◽  
Riccardo Castelli ◽  
Emanuele Cozzani ◽  
Aurora Parodi
Keyword(s):  
Plaque Psoriasis ◽  
Real Life ◽  
Severe Plaque Psoriasis ◽  
The Real ◽  
Real Life Setting

scholarly journals Effectiveness and safety of secukinumab in patients with moderate-to-severe plaque psoriasis – a real life retrospective study

2020 ◽  
Author(s):  
Katarzyna Galica ◽  
Aleksandra Lesiak ◽  
Magdalena Ciążyńska ◽  
Marcin Noweta ◽  
Igor Bednarski ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Plaque Psoriasis ◽  
Real Life ◽  
Severe Plaque Psoriasis

Efficacy and safety of long-acting pasireotide in acromegalic patients in the real life: The reappraisal of the first-dose follow-up visit

2020 ◽  
Author(s):  
Claudio Urbani ◽  
Francesca Dassie ◽  
Benedetta Zampetti ◽  
Di Certo Agostino Maria ◽  
Renato Cozzi ◽  
...  
Keyword(s):  
Real Life ◽  
Efficacy And Safety ◽  
The Real ◽  
Long Acting
Sign in / Sign up

Export Citation Format

Share Document